Loading...
Cross-resistance studies on two K562 sublines resistant to diaziridinylbenzoquinones.
Ward, Timothy H Haran, M Sally Whittaker, Dee Watson, Amanda J Howard, Tina D Butler, John
Ward, Timothy H
Haran, M Sally
Whittaker, Dee
Watson, Amanda J
Howard, Tina D
Butler, John
Citations
Altmetric:
Abstract
Two resistant K562 sublines have been developed by treatment with AZQ (2,5-bis(carboethoxyamino)-3,6-diaziridinyl-1,4-benzoquinone) and BZQ (2,5-bis(2-hydroxyethylamino)-3,6-diaziridinyl-1,4-benzoquinone). The ID50 values of for AZQ on K562, the AZQ-resistant sublines (AZQR) and the BZQ-resistant sublines (BZQR) were 0.063, 1.47 and 0.244 microM, respectively. The relative ID50 values for BZQ on the same cell lines were 0.2, 0.67 and 0.83 microM, respectively. Although it is generally believed that these two quinones function by different mechanisms, the two sublines have similar decreased levels of cytochrome P-450 reductase and DT-diaphorase and increased levels of glutathione and superoxide dismutase, compared to the parent cell line. The sublines are also cross-resistant to adriamycin, mitozolamide, N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) and mitomycin C. This work indicates the potential multifactorial mechanisms by which drug resistance can be induced in cell lines in the absence of conventional 'P'-glycoprotein multidrug resistance.
Description
Date
1995-08-08
Publisher
Collections
Keywords
Type
Article
Citation
Cross-resistance studies on two K562 sublines resistant to diaziridinylbenzoquinones. 1995, 50 (4):459-64 Biochem. Pharmacol.